Six months azithromycin treatment in COPD patients reduces frequency of exacerbations and dalays time to first exacerbation
ViewAtorvastatin Reduces Plasma Inflammatory and Oxidant Biomarkers in Patients With Risk of Atherosclerotic Cardiovascular Disease
ViewLong-term treatment with pioglitazone reduces insulin resistance and prevents progression of atherosclerosis and coronary heart disease
ViewEffect of Prior Atorvastatin Therapy on Frequency of Hospital-Acquired Pneumonia and associated Biomarkers in Acute Ischemic Stroke: A Multicenter Study
ViewTelmisartan improves vascular endothelial dysfunction in coronary slow flow phenomenon (CSFP)
ViewModerate statin treatment reduces prebeta-1 high-density lipoprotein (HDL) levels in dyslipidemic patients
ViewIncreased Coagulation With Aging: Importance of Homocysteine and Vitamin B12
ViewMonotherapy and Dual Combination Therapies Based on Olmesartan: A Comprehensive Strategy to Improve BP Control (RECENT EVIDENCE)
ViewAzithromycin Exerts Anti-inflammatory Effects in Adults with Severe Influenza
ViewAmoxicillin/clavulanate can Prevent Bacteraemia following Dental Procedures
View